Skip To Main Content
This website contains promotional content and is intended for Healthcare Professionals in the Republic of Ireland only. Adverse event reporting can be found at the bottom of the page
Campus
Campus

Dyslipidaemia

Experts

Identifying and treating patients with high lipidaemic risk post-ACS - Professor Perrone-Filardi

An expert interview with Professor Perrone-Filardi

Learn more
Fixed dose combinations are the future of cardiovascular medicines - an expert interview - Professor Michal Vrablik

An expert Interview with Professor Vrablik

Learn more

Our Products

Suvezen® Product Page

Click here for Prescribing Information

 

MAT-IE-2300173 (v3.0)
Date of preparation: April 2024

MAT-IE-2300205 (v2.0)  
Date of Preparation: May 2024